Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND)

Abroad (travel likely)RecruitingPHASE2

Conditions

Treatment Resistant Depression · Chronic Pain

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Centre for Addiction and Mental Health, Toronto, Ontario, Canada
Contact: Study coordinator (Alex Coles, MSc) · psychedelics.research@camh.ca · 4165358501
Contact: Principal Investigator (M. Ishrat Husain, MBBS, MD)

Study leads

Muhammad Ishrat Husain, MBBS, MD
Principal Investigator
Centre for Addiction and Mental Health

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Psilocybin for Hospitalized Patients with Treatment-resistant Depression

Treatment Resistant Depression

Abroad (travel likely)RecruitingPHASE2

Ghent, Belgium

An Open-Label Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression

Treatment Resistant Depression

Abroad (travel likely)RecruitingPHASE2

Liverpool, United Kingdom · London, United Kingdom

i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial

Major Depressive Disorder · Suicide · Treatment Resistant Depression

Abroad (travel likely)RecruitingPHASE2

Toronto, Canada

OSU6162 as add-on in SSRI/SNRI-resistant Depression

Depression · Depressive Disorder, Treatment-Resistant · Depressive Disorder

Abroad (travel likely)RecruitingPHASE2

Lund, Sweden · Gothenburg, Sweden